TARGETING NAKED RNA WITH SMALL MOLECULE DRUGS
Opening Avenues for Novel
Patient Treatments
About Ranar Therapeutics
Focus
Technology
Technology
Most therapeutic approaches today target proteins – though there are a wide array of undruggable proteins and non-protein targets that are implicated in disease and remain un-addressable. RANAR Therapeutics is developing small molecules that directly bind to RNA to address these targets.
Technology
Technology
Technology
RANAR Therapeutics is using a focused library approach based on privileged chemical scaffolds to ID compounds that bind RNA & disrupt function. Our exclusive collaborations and deep understanding of RNA structure, coupled with proprietary focused compounds increase our probability of success in identifying compounds to alter RNA function.
Team
Technology
Team
We are a team of scientists, business leaders, and innovators on a mission to effectively target RNA with drug-like small molecules to greatly expand the universe of targets and address inadequately served patients. Meet our leadership, board of directors, and scientific advisory board.